vs
Amprius Technologies, Inc.（AMPX）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Amprius Technologies, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$25.2M vs $19.6M），Amprius Technologies, Inc.净利率更高（-96.7% vs -177.4%，领先80.7%），Amprius Technologies, Inc.同比增速更快（137.4% vs -11.5%），Amprius Technologies, Inc.自由现金流更多（$-5.9M vs $-23.1M），过去两年Amprius Technologies, Inc.的营收复合增速更高（228.7% vs -12.2%）
Amprius Technologies是一家先进储能技术企业，主打自研硅负极技术的高能量密度锂离子电池，产品覆盖航空航天、国防、电动出行、便携式电子设备等领域，可提供续航更长、充电速度更快的电池解决方案。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
AMPX vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.2M | $19.6M |
| 净利润 | $-24.4M | $-34.7M |
| 毛利率 | 23.6% | 48.5% |
| 营业利润率 | -100.9% | -168.5% |
| 净利率 | -96.7% | -177.4% |
| 营收同比 | 137.4% | -11.5% |
| 净利润同比 | -113.6% | -28.8% |
| 每股收益（稀释后） | $-0.19 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $25.2M | — | ||
| Q3 25 | $21.4M | $19.6M | ||
| Q2 25 | $15.1M | $21.8M | ||
| Q1 25 | $11.3M | $40.8M | ||
| Q4 24 | $10.6M | — | ||
| Q3 24 | $7.9M | $22.1M | ||
| Q2 24 | $3.3M | $22.5M | ||
| Q1 24 | $2.3M | $45.5M |
| Q4 25 | $-24.4M | — | ||
| Q3 25 | $-3.9M | $-34.7M | ||
| Q2 25 | $-6.4M | $-33.5M | ||
| Q1 25 | $-9.4M | $-26.0M | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $-10.8M | $-26.9M | ||
| Q2 24 | $-12.5M | $-45.7M | ||
| Q1 24 | $-9.9M | $-32.2M |
| Q4 25 | 23.6% | — | ||
| Q3 25 | 15.5% | 48.5% | ||
| Q2 25 | 8.9% | 48.8% | ||
| Q1 25 | -20.9% | 48.4% | ||
| Q4 24 | -21.2% | — | ||
| Q3 24 | -64.9% | 54.9% | ||
| Q2 24 | -195.2% | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | -100.9% | — | ||
| Q3 25 | -21.9% | -168.5% | ||
| Q2 25 | -45.2% | -118.1% | ||
| Q1 25 | -85.7% | -80.8% | ||
| Q4 24 | -110.6% | — | ||
| Q3 24 | -143.3% | -120.9% | ||
| Q2 24 | -386.6% | -134.5% | ||
| Q1 24 | -441.7% | -132.2% |
| Q4 25 | -96.7% | — | ||
| Q3 25 | -18.2% | -177.4% | ||
| Q2 25 | -42.3% | -153.7% | ||
| Q1 25 | -83.0% | -63.8% | ||
| Q4 24 | -107.4% | — | ||
| Q3 24 | -138.1% | -122.0% | ||
| Q2 24 | -374.2% | -203.3% | ||
| Q1 24 | -423.2% | -70.6% |
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $-0.03 | $-0.09 | ||
| Q2 25 | $-0.05 | $-0.09 | ||
| Q1 25 | $-0.08 | $-0.07 | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.10 | $-0.07 | ||
| Q2 24 | $-0.13 | $-0.12 | ||
| Q1 24 | $-0.11 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.5M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $103.8M | $399.7M |
| 总资产 | $156.9M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $90.5M | — | ||
| Q3 25 | $73.2M | $129.4M | ||
| Q2 25 | $54.2M | $158.6M | ||
| Q1 25 | $48.4M | $150.9M | ||
| Q4 24 | $55.2M | — | ||
| Q3 24 | $35.0M | $210.6M | ||
| Q2 24 | $46.4M | $269.8M | ||
| Q1 24 | $39.0M | $287.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
| Q4 25 | $103.8M | — | ||
| Q3 25 | $103.2M | $399.7M | ||
| Q2 25 | $76.7M | $424.5M | ||
| Q1 25 | $70.4M | $454.6M | ||
| Q4 24 | $69.5M | — | ||
| Q3 24 | $56.0M | $489.3M | ||
| Q2 24 | $65.1M | $510.3M | ||
| Q1 24 | $59.9M | $577.3M |
| Q4 25 | $156.9M | — | ||
| Q3 25 | $156.5M | $539.6M | ||
| Q2 25 | $123.0M | $557.0M | ||
| Q1 25 | $118.5M | $579.6M | ||
| Q4 24 | $121.1M | — | ||
| Q3 24 | $104.2M | $681.5M | ||
| Q2 24 | $112.8M | $708.7M | ||
| Q1 24 | $104.7M | $777.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.5M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-5.9M | $-23.1M |
| 自由现金流率自由现金流/营收 | -23.2% | -118.1% |
| 资本支出强度资本支出/营收 | 9.3% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-35.5M | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-9.2M | $-22.2M | ||
| Q2 25 | $-4.3M | $-20.7M | ||
| Q1 25 | $-14.1M | $-30.3M | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | $-9.5M | $-27.9M | ||
| Q2 24 | $-8.0M | $-39.0M | ||
| Q1 24 | $-9.8M | $-62.5M |
| Q4 25 | $-5.9M | — | ||
| Q3 25 | $-9.7M | $-23.1M | ||
| Q2 25 | $-5.0M | $-22.6M | ||
| Q1 25 | $-15.0M | $-35.3M | ||
| Q4 24 | $-9.7M | — | ||
| Q3 24 | $-10.9M | $-30.1M | ||
| Q2 24 | $-9.6M | $-41.0M | ||
| Q1 24 | $-13.7M | $-63.3M |
| Q4 25 | -23.2% | — | ||
| Q3 25 | -45.1% | -118.1% | ||
| Q2 25 | -33.1% | -103.6% | ||
| Q1 25 | -133.3% | -86.6% | ||
| Q4 24 | -91.4% | — | ||
| Q3 24 | -138.3% | -136.4% | ||
| Q2 24 | -285.9% | -182.2% | ||
| Q1 24 | -585.4% | -138.9% |
| Q4 25 | 9.3% | — | ||
| Q3 25 | 1.9% | 4.5% | ||
| Q2 25 | 4.8% | 8.7% | ||
| Q1 25 | 8.1% | 12.4% | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 17.0% | 10.2% | ||
| Q2 24 | 48.0% | 8.6% | ||
| Q1 24 | 166.8% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPX
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
